Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma Patient

Summary Tumor lysis syndrome (TLS) is rarely induces after Transarterial chemoembolization for hepatocellular carcinoma. We present a patient with a large hepatocellular carcinoma who received twice transarterial embolization (TAE). Tumor lysis syndrome was induced after the first TACE in this patie...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of gerontology Vol. 8; no. 3; pp. 171 - 174
Main Authors Lin, Hsaing-Hung, Chang, Wei-Ho, Wang, Horng-Yuan, Chen, Ming-Jen, Shih, Shou-Chuan
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2014
Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM)
Subjects
hepatocellular carcinoma
Internal Medicine
transarterial chemoembolization
tumor lysis syndrome
transarterial chemoembolization
tumor lysis syndrome
hepatocellular carcinoma
Online AccessGet full text

Cover

More Information
Summary:Summary Tumor lysis syndrome (TLS) is rarely induces after Transarterial chemoembolization for hepatocellular carcinoma. We present a patient with a large hepatocellular carcinoma who received twice transarterial embolization (TAE). Tumor lysis syndrome was induced after the first TACE in this patient. Due to the previous experience, precautionary measures were taken before the second TAE. Therefore no complications were noted afterwards. We should be aware of tumor lysis syndrome, especially in high risk patients.
ISSN:1873-9598
DOI:10.1016/j.ijge.2014.03.005